Showing results (161-170 of 178) with videos related to
Sort By:
Pageof 18
Elife|July 11, 2023
SNORD90 induces glutamatergic signaling following treatment with monoaminergic antidepressantsRixing Lin, Aron Kos, Juan Pablo Lopez, et al.Bipolar Disorders|July 10, 2026
Establishing a Specialty Bipolar Clinic: The National Network of Depression Centers Consensus RecommendationsChristopher D Schneck, Jorge R C Almeida, David J Bond, et al.Innovations in Clinical Neuroscience|February 1, 2021
THE DEPRESSION INVENTORY DEVELOPMENT SCALE: Assessment of Psychometric Properties Using Classical and Modern Measurement Theory in a CAN-BIND TrialAnthony L Vaccarino, Amir H Kalali, Pierre Blier, et al.JMIR Formative Research|January 24, 2024
Correction: Evaluating the Clinical Feasibility of an Artificial Intelligence-Powered, Web-Based Clinical Decision Support System for the Treatment of Depression in Adults: Longitudinal Feasibility StudyChristina Popescu, Grace Golden, David Benrimoh, et al.Bipolar Disorders|October 2, 2021
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentationsLakshmi N Yatham, Trisha Chakrabarty, David J Bond, et al.Bipolar Disorders|March 15, 2018
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorderLakshmi N Yatham, Sidney H Kennedy, Sagar V Parikh, et al.JMIR Formative Research|October 25, 2021
Evaluating the Clinical Feasibility of an Artificial Intelligence-Powered, Web-Based Clinical Decision Support System for the Treatment of Depression in Adults: Longitudinal Feasibility StudyChristina Popescu, Grace Golden, David Benrimoh, et al.Bjpsych Open|January 6, 2021
Using a simulation centre to evaluate preliminary acceptability and impact of an artificial intelligence-powered clinical decision support system for depression treatment on the physician-patient interactionDavid Benrimoh, Myriam Tanguay-Sela, Kelly Perlman, et al.Clinical Pharmacology and Therapeutics|January 22, 2023
ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta-Analysis Including Results from the CAN-BIND-1 StudyLeen Magarbeh, Claudia Hassel, Maximilian Choi, et al.The Journal of Clinical Psychiatry|March 7, 2019
Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder: A CAN-BIND-1 ReportSidney H Kennedy, Raymond W Lam, Susan Rotzinger, et al.Pageof 18